AVIENCE BIOMEDICALS LTD (AVIENCE) reported revenue of ₹26.82 Cr and net profit of ₹4.54 Cr for the quarter ended 2025-09-30. Figures are parsed from the company's filed results.
The statements below are read from AVIENCE BIOMEDICALS LTD’s filed results, 2 filed quarters and 3 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q2 FY25-26 · filed Jul 24, 2026
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | Mar2025 | Sep2025Latest | YoYlatest |
|---|---|---|---|
| Sales | 24.5 | 26.8 | — |
| Expenses | 17.9 | 19.6 | — |
| Operating profit | 6.61 | 7.25 | — |
| OPM % | 27.0% | 27.0% | — |
| Other income | 0.46 | 0.06 | — |
| Interest | 0.69 | 0.65 | — |
| Depreciation | 0.48 | 0.56 | — |
| Profit before tax | 5.90 | 6.10 | — |
| Tax % | 27.6% | 25.6% | — |
| Net profit | 4.27 | 4.54 | — |
| EPS (₹) | 10.59 | 11.26 | — |
